Table 5

LDL tests performed and LDL test results available by lipid lowering treatment in patients initiating lipid-lowering therapy, including patient subgroups with diabetes (DM) or rheumatoid arthritis (RA)
All patients LDL test performed LDL test results available LDL level HDL level
Initiated medication N % N % N % of total N % of ordered mean s.d. mean s.d.
All Any statin alone 655,211 93 395,496 60.4 165,380 25.2 41.8 145.3 38.6 50.2 14.5
Any statin high intensity* 173,979 25 98,309 56.5 41,320 23.7 42.0 144.2 45.5 49.2 14.3
Any statin low intensity 481,232 68 297,187 61.8 124,060 25.8 41.7 145.7 36 50.6 14.6
Simvastatin alone 282,658 40 176,697 62.5 73,193 25.9 41.4 147.0 36.3 50.2 14.4
Simvastatin high dose (>40 mg) 11,354 2 5,912 52.1 2,192 19.3 37.1 135.6 49.5 48 13.6
Simvastatin low dose 271,304 39 170,785 62.9 71,001 26.2 41.6 147.3 35.8 50.2 14.4
Vytorin alone 24,931 4 12,966 52 6,820 27.4 52.6 142.2 47.6 49.6 14.3
Vytorin high dose (>40 mg simvast) 1,069 0 563 52.7 223 20.9 39.6 124.1 56.7 48.1 13.5
Vytorin low dose 23,862 3 12,403 52 6,597 27.6 53.2 142.8 47.1 49.6 14.4
Ezetimibe alone 20,509 3 11,412 55.6 5,334 26 46.7 143.2 38.1 51.5 14.9
Ezetimibe + statin 2,833 0 1,834 64.7 720 25.4 39.3 145.7 47.7 48.2 13.5
Total: 703,484
DM Any statin alone 103,664 93 69,788 67.3 25,927 25 37.2 124.8 37.4 46.5 13.1
Any statin high intensity* 28,472 26 18,069 63.5 6,909 24.3 38.2 122.3 43.3 45.8 13.1
Any statin low intensity 75,192 67 51,719 68.8 19,018 25.3 36.8 125.7 35.0 46.8 13.1
Simvastatin alone 46,414 42 32,207 69.4 11,670 25.1 36.2 126.8 35.6 46.5 13.0
Simvastatin high dose (>40 mg) 2,498 2 1,513 60.6 521 20.9 34.4 117.1 46.2 45.6 12.6
Simvastatin low dose 43,916 39 30,694 69.9 11,149 25.4 36.3 127.2 35.0 46.6 13.0
Vytorin alone 4,049 4 2,324 57.4 1,086 26.8 46.7 122.9 44.4 45.6 13.4
Vytorin high dose (>40 mg simvast) 269 0 169 62.8 58 21.6 34.3 105.6 41.6 46.3 14.0
Vytorin low dose 3,780 3 2,155 57 1,028 27.2 47.7 123.8 44.4 45.6 13.4
Ezetimibe alone 3,459 3 2,092 60.5 884 25.6 42.3 126.9 37.7 47.0 13.1
Ezetimibe + statin 512 1 372 72.7 135 26.4 36.3 133.1 44.5 44.8 11.8
Total: 111,684
RA Any statin alone 4,118 91 2,425 58.9 833 20.2 34.4 138.5 39.4 54.7 16.5
Any statin high intensity* 1,044 23 575 55.1 205 19.6 35.7 135.4 50.9 53.6 17.8
Any statin low intensity 3,074 68 1,850 60.2 628 20.4 33.9 139.5 34.8 55.1 16.0
Simvastatin alone 1,749 39 1,070 61.2 360 20.6 33.6 141.6 33.4 54.3 15.5
Simvastatin high dose (>40 mg) 70 2 37 52.9 14 20 37.8 134.6 44.2 46.5 12.0
Simvastatin low dose 1,679 37 1,033 61.5 346 20.6 33.5 141.9 32.9 54.6 15.6
Vytorin alone 174 4 85 48.9 43 24.7 50.6 142.6 45.6 52.8 16.3
Vytorin high dose (>40 mg simvast) 9 0 4 44.4 2 22.2 50.0 177.0 76.4 52 22.6
Vytorin low dose 165 4 81 49.1 41 24.8 50.6 141.0 44.5 52.8 16.3
Ezetimibe alone 210 5 126 60 55 26.2 43.7 137.5 31.3 56.8 16.7
Ezetimibe + statin 21 1 14 66.7 4 19 28.6 144.0 45.5 49.0 10.4
Total: 4,523

* See methods section for definition.

Schneeweiss et al.

Schneeweiss et al. BMC Medical Research Methodology 2012 12:180   doi:10.1186/1471-2288-12-180

Open Data